Juria Muramatsu
Papers
1
Total Citations
2
H-Index
1
About
Juria Muramatsu is a radiation oncologist whose work focuses on the precision treatment of oligometastatic disease, particularly through stereotactic body radiotherapy (SBRT). Her most-cited paper, "Stereotactic Body Radiotherapy for Lymph Node Oligometastases" (2019), explores the use of high-dose, precisely targeted radiation to control limited metastatic spread in lymph nodes, a strategy that aims to delay systemic therapy and improve patient outcomes. While her citation count is still growing, this work contributes to the evolving paradigm of metastasis-directed therapy, offering a non-invasive alternative for patients with a limited number of secondary tumors. Muramatsu’s research underscores the potential of SBRT in oligometastatic management, a field that is rapidly gaining traction in oncology. Her contributions are particularly valuable for students and researchers interested in the intersection of radiation technology and personalized cancer care, highlighting how targeted radiotherapy can reshape treatment pathways for patients with advanced but limited disease.
Research Focus
Key Achievements
Top Papers
- 1Stereotactic Body Radiotherapy for Lymph Node Oligometastases.2 citations · 2019